NEA Management Company, LLC
26 holdingsFiling period: 2026-06-30Current AUM: $1.47Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | TRVI | Trevi Therapeutics, Inc. | 13.22M | $246.6M | $198.9M | 13.50% | -- | 2026-06-30 |
| 2 | MBX | MBX Biosciences, Inc. | 3.61M | $199.5M | $220.8M | 14.99% | -- | 2026-06-30 |
| 3 | GLUE | Monte Rosa Therapeutics, Inc. | 7.69M | $186.2M | $99.9M | 6.78% | -- | 2026-06-30 |
| 4 | CELC | Celcuity Inc. | 1.71M | $179.0M | $141.5M | 9.60% | -575,000 | 2026-06-30 |
| 5 | SGP | Spyglass Pharma, Inc. | 7.39M | $164.6M | $214.1M | 14.53% | -- | 2026-06-30 |
| 6 | SVRA | Savara, Inc. | 24.47M | $150.7M | $128.7M | 8.74% | -- | 2026-06-30 |
| 7 | ZBIO | Zenas BioPharma, Inc. | 4.02M | $102.1M | $128.5M | 8.72% | -- | 2026-06-30 |
| 8 | COUR | Coursera, Inc. | 12.87M | $72.6M | $67.9M | 4.61% | -- | 2026-06-30 |
| 9 | AUPH | Aurinia Pharmaceuticals, Inc. | 3.97M | $67.4M | $64.0M | 4.35% | -- | 2026-06-30 |
| 10 | — | CRISPR Therapeutics AG | 1.06M | $57.7M | $57.7M | 3.92% | -- | 2026-06-30 |
| 11 | ORIC | ORIC Pharmaceuticals, Inc. | 4.12M | $44.6M | $50.9M | 3.46% | -- | 2026-06-30 |
| 12 | PHAT | Phathom Pharmaceuticals, Inc. | 1.96M | $21.3M | $16.0M | 1.09% | -- | 2026-06-30 |
| 13 | KRRO | Korro Bio, Inc. | 1.30M | $17.1M | $18.3M | 1.24% | -- | 2026-06-30 |
| 14 | ASNS | X4 Pharmaceuticals, Inc. | 3.23M | $15.1M | $15.1M | 1.03% | -- | 2026-06-30 |
| 15 | CSBR | Champions Oncology, Inc. | 1.71M | $10.6M | $8.2M | 0.55% | -- | 2026-06-30 |
| 16 | NKTX | Nkarta, Inc. | 3.57M | $10.1M | $10.3M | 0.70% | -- | 2026-06-30 |
| 17 | CVRX | CVRx, Inc. | 1.95M | $10.0M | $5.9M | 0.40% | -71,643 | 2026-06-30 |
| 18 | BDTX | Black Diamond Therapeutics, Inc. | 4.45M | $8.2M | $8.8M | 0.59% | -- | 2026-06-30 |
| 19 | KPTI | Karyopharm Therapeutics Inc. | 576.8K | $5.6M | $888K | 0.06% | -- | 2026-06-30 |
| 20 | IVA | Inventiva SA | 1.46M | $5.5M | $5.6M | 0.38% | -- | 2026-06-30 |
| 21 | LONA | LeonaBio, Inc. | 464.4K | $4.3M | $3.4M | 0.23% | -- | 2026-06-30 |
| 22 | — | Senti Biosciences, Inc. | 3.78M | $4.2M | $4.2M | 0.28% | -- | 2026-06-30 |
| 23 | MRKR | Marker Therapeutics, Inc. | 1.63M | $2.4M | $1.9M | 0.13% | -- | 2026-06-30 |
| 24 | OKUR | OnKure Therapeutics, Inc. | 478.5K | $2.2M | $1.4M | 0.10% | -- | 2026-06-30 |
| 25 | IMA | ImageneBio, Inc. | 50.0K | $295K | $246K | 0.02% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2